Text Size
482 studies found for:    "bladder cancer"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting Evaluation of Non-Invasive Assay(s) for the Detection of Bladder Cancer
Conditions: Bladder Cancer;   Cancer;   Bladder Neoplasms;   Urinary Bladder Cancer
Intervention:
2 Completed Gene Therapy in Treating Patients With Advanced Bladder Cancer
Conditions: Recurrent Bladder Cancer;   Stage I Bladder Cancer;   Stage II Bladder Cancer;   Stage III Bladder Cancer;   Stage IV Bladder Cancer;   Transitional Cell Carcinoma of the Bladder
Intervention: Biological: Ad5CMV-p53 gene
3 Recruiting Broccoli Sprout Extract in Treating Patients With Transitional Cell Bladder Cancer Undergoing Surgery
Conditions: Recurrent Bladder Cancer;   Stage 0 Bladder Cancer;   Stage I Bladder Cancer;   Stage II Bladder Cancer;   Transitional Cell Carcinoma of the Bladder
Interventions: Drug: broccoli sprout extract;   Other: laboratory biomarker analysis
4 Recruiting Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
Conditions: Stage I Bladder Cancer;   Stage II Bladder Cancer;   Stage III Bladder Cancer;   Transitional Cell Carcinoma of the Bladder
Interventions: Drug: paclitaxel;   Biological: trastuzumab;   Radiation: radiation therapy
5 Recruiting Neoadjuvant Intravesical Vaccine Therapy in Treating Patients With Bladder Carcinoma Who Are Undergoing Cystectomy
Conditions: Adenocarcinoma of the Bladder;   Recurrent Bladder Cancer;   Squamous Cell Carcinoma of the Bladder;   Stage 0 Bladder Cancer;   Stage I Bladder Cancer;   Stage II Bladder Cancer;   Stage III Bladder Cancer;   Transitional Cell Carcinoma of the Bladder
Interventions: Procedure: conventional surgery;   Biological: recombinant fowlpox-TRICOM vaccine
6 Active, not recruiting Molecular Analysis Of Bladder Cancer
Conditions: Bladder Cancer;   Bladder Neoplasms
Intervention:
7 Active, not recruiting Gemcitabine, Paclitaxel, Doxorubicin in Metastatic or Unresectable Bladder Cancer With Decreased Kidney Function
Conditions: Distal Urethral Cancer;   Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter;   Proximal Urethral Cancer;   Recurrent Bladder Cancer;   Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter;   Recurrent Urethral Cancer;   Regional Transitional Cell Cancer of the Renal Pelvis and Ureter;   Stage III Bladder Cancer;   Stage IV Bladder Cancer;   Transitional Cell Carcinoma of the Bladder;   Urethral Cancer Associated With Invasive Bladder Cancer
Interventions: Drug: gemcitabine hydrochloride;   Drug: paclitaxel;   Drug: doxorubicin hydrochloride;   Drug: pegfilgrastim
8 Active, not recruiting Prostate Capsule Sparing Cystectomy and Nerve-sparing Radical Cystoprostatectomy in Men With Bladder Cancer
Conditions: Bladder Cancer;   Transitional Cell Carcinoma of the Bladder
Interventions: Procedure: Prostate capsule sparing cystectomy;   Procedure: Nerve sparing cystectomy
9 Active, not recruiting Genetic Susceptibility to Tumor Recurrence and Progression in Patients With Non-Muscle Invasive Bladder Cancer
Conditions: Bladder Cancer;   Urinary Cancer;   Nonmuscle Invasive Bladder Cancer
Intervention: Genetic: Questionaire, specimen samples
10 Terminated Green Tea Extract in Treating Patients With Nonmetastatic Bladder Cancer
Conditions: Stage I Bladder Cancer;   Stage II Bladder Cancer;   Stage III Bladder Cancer
Interventions: Dietary Supplement: defined green tea catechin extract;   Drug: placebo;   Procedure: therapeutic conventional surgery;   Other: pharmacological study;   Other: laboratory biomarker analysis
11 Recruiting Cabozantinib for Advanced Urothelial Cancer
Conditions: Micropapillary Cancer of the Bladder;   Squamous Cell Carcinoma of the Bladder;   Bladder Cancer With Bone Metastases;   Bladder Cancer;   Small Cell Cancer of the Bladder;   Urachal Cancer;   Sarcomatoid Bladder Cancer
Interventions: Drug: Cabozantinib;   Procedure: FDG PET CT;   Procedure: NaF PET CT
12 Completed
Has Results 		Study of Pralatrexate to Treat Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary Bladder
Conditions: Carcinoma, Transitional Cell;   Bladder Cancer;   Bladder Neoplasm
Interventions: Drug: Pralatrexate Injection;   Dietary Supplement: Vitamin B12;   Dietary Supplement: Folic Acid
13 Completed Sorafenib in Treating Patients With Advanced or Metastatic Cancer of the Urinary Tract
Conditions: Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter;   Recurrent Bladder Cancer;   Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter;   Regional Transitional Cell Cancer of the Renal Pelvis and Ureter;   Stage III Bladder Cancer;   Stage IV Bladder Cancer;   Transitional Cell Carcinoma of the Bladder
Interventions: Drug: sorafenib tosylate;   Other: laboratory biomarker analysis
14 Completed
Has Results 		A Phase II Study of AZD4877 (a Novel Anti-mitotic Agent) in Advanced Bladder Cancer
Conditions: Bladder Cancer;   Transitional Cell Bladder Cancer;   Urethra Cancer;   Ureter Cancer;   Renal Pelvis Cancer
Intervention: Drug: AZD4877
15 Completed
Has Results 		Mitomycin C With Hyperthermia and Intravesical Mitomycin C to Treat Recurrent Bladder Cancer
Conditions: Transitional Cell Carcinoma of Bladder;   Superficial Bladder Cancer
Interventions: Device: Hyperthermia System;   Drug: Mitomycin C
16 Terminated Celecoxib and Rosiglitazone in Treating Patients Who Are Undergoing Cystoscopic Surveillance for Early-Stage Noninvasive Carcinoma of the Bladder or Radical Cystectomy for Muscle-Invasive Carcinoma of the Bladder
Condition: Bladder Cancer
Interventions: Drug: celecoxib;   Drug: rosiglitazone maleate;   Procedure: conventional surgery;   Procedure: neoadjuvant therapy
17 Active, not recruiting Comparison of Immediate and Delayed Adjuvant Chemotherapy in Treating Patients Who Have Undergone a Radical Cystectomy for Stage III or Stage IV Transitional Cell Carcinoma of the Bladder Urothelium
Conditions: Stage III Bladder Cancer;   Stage IV Bladder Cancer;   Transitional Cell Carcinoma of the Bladder
Interventions: Drug: doxorubicin hydrochloride;   Drug: gemcitabine hydrochloride;   Drug: vinblastine sulfate;   Drug: methotrexate;   Drug: cisplatin;   Biological: filgrastim
18 Unknown † Standard Surgery or Minimal-Access Surgery in Treating Patients With Bladder Cancer
Condition: Bladder Cancer
Interventions: Other: questionnaire administration;   Procedure: quality-of-life assessment;   Procedure: robot-assisted laparoscopic surgery;   Procedure: therapeutic conventional surgery;   Procedure: therapeutic laparoscopic surgery
19 Unknown † Peptide Vaccine Focusing on Prevention of the Recurrence for Bladder Cancer
Condition: Bladder Cancer
Intervention: Biological: MPHOSPH1 and DEPDC1
20 Terminated
Has Results 		Sorafenib in Treating Patients With Regional or Metastatic Cancer of the Urothelium
Conditions: Adenocarcinoma of the Bladder;   Distal Urethral Cancer;   Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter;   Proximal Urethral Cancer;   Recurrent Bladder Cancer;   Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter;   Recurrent Urethral Cancer;   Regional Transitional Cell Cancer of the Renal Pelvis and Ureter;   Squamous Cell Carcinoma of the Bladder;   Stage III Bladder Cancer;   Stage IV Bladder Cancer;   Transitional Cell Carcinoma of the Bladder;   Urethral Cancer Associated With Invasive Bladder Cancer
Interventions: Drug: sorafenib tosylate;   Other: laboratory biomarker analysis;   Other: pharmacogenomic studies;   Other: pharmacological study
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years